Lobbying Information
Subject Matters
- Energy
- Environment
- Health
- Industry
- International Trade
- Science and Technology
Subject Matter Details
Policies or Program
- Cross-border initiatives relating to improving the efficiency of trade under the Security and Prosperity Partnership specifically related to the efficient and secure transportation of medical isotopes.
- Interested in the ongoing reliable supply of medical isotopes from Atomic Energy of Canada Limited (AECL) a Crown Corporation regulated by the Government of Canada
- Nuclear Safety and Control Act - Canada's policy position with respect to nuclear security and safety
Regulation
- Transportation of Dangerous Goods Act - standards relating to the effective, efficient, safe and secure transport of Class 7 materials and specifically those with a medical application.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canada Border Services Agency (CBSA)
-
Canadian Institutes of Health Research (CIHR)
-
Canadian Nuclear Safety Commission (CNSC)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
Industry Canada
-
National Research Council (NRC)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Safety Canada (PS)
-
Transport Canada (TC)
In-house Corporation Details
Description of activities
MDS Nordion, is a division of MDS (Canada) Inc., a world leader in medical isotopes, radiation and related technologies.
Responsible officer name and position during the period of this registration
Douglas Prince,
President, MDS (Canada) Inc.
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
2810 Matheson Boulevard East
Suite 500
Mississauga, ON L4W 4X7
Canada
Telephone number:
905-267-4222
Fax number:
905-267-4252
Parent Company Information
- Laboratoires MDS Quebec Ltee
-
4800 Dobrin
Suite 100
St. Laurent, QC H4R 2P8
Canada
Subsidiary Beneficiary Information
MDS (Canada) Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Peter Covitz,
SVP, Innovation, MDS Nordion, a division of MDS (Canada) Inc. |
No public offices held
- Ron McGregor,
SVP Quality, Reg Affairs, S & E, MDS Nordion, a division of MDS (Canada) Inc. |
No public offices held
- Douglas Prince,
President, MDS (Canada) Inc. |
No public offices held
- Steve West,
President, MDS Nordion, a division of MDS (Canada) Inc. |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Jill Chitra,
Vice-President Strategic Technologies, MDS Nordion, a division of MDS (Canada) Inc. |
No public offices held
